Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Current preclinical models to investigate human HR + breast cancer progression and response to immunotherapy in vivo are limited. Here, the authors demonstrate that mammary tumours driven by a synthetic progestin combined with an oral carcinogen recapitulate several immunobiological features of huma...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a7e37a6ac2cb4091b97dc956fd1c341a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|